Inhibition of GSK-3β in pancreatic cancer cells using LiCl, AR-A014418, or SB216763 GSK inhibitors.Targeting GSK-3β by siRNAs in pancreatic cancer cell lines. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.